These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1425732)

  • 1. A case of prolonged urinary tract infection caused by Mycobacterium fortuitum.
    Hochman I; Siegman-Igra Y; Goor Y; Cabili S
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):725-7. PubMed ID: 1425732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Mycobacterium fortuitum infection.
    Oren B; Raz R; Hass H
    Infection; 1990; 18(2):105-6. PubMed ID: 2332244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary infection due to Mycobacterium fortuitum in a patient with HIV infection].
    Valencia ME; Quiles MI
    Rev Esp Quimioter; 2016 Aug; 29(4):226-7. PubMed ID: 27262572
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterium fortuitum infection masquerading as an orbital mass.
    Ali S; Sivak-Callcott JA; Khakoo R; Williams HJ
    Ophthalmic Plast Reconstr Surg; 2007; 23(4):327-9. PubMed ID: 17667115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium fortuitum Complex Skin Infection in a Healthy Adolescent.
    Sparks R; Khatami A
    Infect Disord Drug Targets; 2014; 14(3):168-71. PubMed ID: 25019232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft-tissue infection due to Mycobacterium smegmatis: report of two cases.
    Newton JA; Weiss PJ; Bowler WA; Oldfield EC
    Clin Infect Dis; 1993 Apr; 16(4):531-3. PubMed ID: 8513061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.
    Nagore E; Ramos P; Botella-Estrada R; Ramos-Níguez JA; Sanmartín O; Castejón P
    Acta Derm Venereol; 2001; 81(4):291-3. PubMed ID: 11720180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of urinary mycobacterium fortuitum in a patient with urinary tract tuberculosis posttreatment].
    Maehana T; Takahashi S; Hirobe M; Taguchi K
    Hinyokika Kiyo; 2008 Nov; 54(11):741-3. PubMed ID: 19068730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal abscess caused by Mycobacterium chelonae and treatment.
    Idemyor V; Cherubin CE
    Ann Pharmacother; 1993 Feb; 27(2):178-9. PubMed ID: 8439693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium fortuitum infection of ventriculoperitoneal shunt.
    Midani S; Rathore MH
    South Med J; 1999 Jul; 92(7):705-7. PubMed ID: 10414479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.
    Burman WJ; Breese PE; Murray BE; Singh KV; Batal HA; MacKenzie TD; Ogle JW; Wilson ML; Reves RR; Mehler PS
    Am J Med; 2003 Oct; 115(5):358-64. PubMed ID: 14553870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium fortuitum infection arising in a new tattoo.
    Philips RC; Hunter-Ellul LA; Martin JE; Wilkerson MG
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium fortuitum lung abscess: resolution with prolonged trimethoprim/sulfamethoxazole therapy.
    Pacht ER
    Am Rev Respir Dis; 1990 Jun; 141(6):1599-601. PubMed ID: 2350102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin disease and nontuberculous atypical mycobacteria.
    Palenque E
    Int J Dermatol; 2000 Sep; 39(9):659-66. PubMed ID: 11044189
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventriculoperitoneal shunt infection with Mycobacterium fortuitum: a rare offending organism.
    Cadena G; Wiedeman J; Boggan JE
    J Neurosurg Pediatr; 2014 Dec; 14(6):704-7. PubMed ID: 25325413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison.
    Grubbs NC; Schultz HJ; Henry NK; Ilstrup DM; Muller SM; Wilson WR
    Mayo Clin Proc; 1992 Dec; 67(12):1163-8. PubMed ID: 1469927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of urinary tract infections with fosfomycin and trimethoprim-sulfamethoxazole: a case report.
    van Duin D
    J Chemother; 2011 Feb; 23(1):55-6. PubMed ID: 21482498
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of severe cutaneous
    Kobayashi T; Ford B; Sekar P
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.